Skip to main content
. 2018 Nov 9;8:16611. doi: 10.1038/s41598-018-34543-z

Table 4.

Comparison of clinicopathologic characteristics between patients with low NLR and high NLR; low PNI and high PNI.

Factors Low NLR <2.5 High NLR >2.5 P Low PNI <40 High PNI >40 P
n = 77 n = 41 n = 48 n = 70
Age, years 68.7 ± 10.6 70.7 ± 10.1 0.334 68.4 ± 10.9 70.1 ± 10.1 0.395
Gender, male 47 (61) 27 (66) 0.691 28 (48) 46 (66) 0.44
Diabetes mellitus 28 (36) 23 (56) 0.051 25 (52) 26 (37) 0.131
End-stage renal disease 4 (5) 4 (10) 0.446 4 (8) 4 (6) 0.714
HBsAg positive 20 (26) 12 (29) 0.828 17 (35) 15 (21) 0.139
Anti-HCV positive 60 (78) 28 (68) 0.273 34 (71) 54 (77) 0.52
Major tumor size (≥3 cm) 13 (17) 14 (34) 0.040 10 (21) 17 (24) 0.824
Tumor stage II 23 (30) 7 (17) 0.183 12 (25) 18 (26) 1
AFP (>200 ng/mL) 3 (4) 5 (12) 0.124 3 (6) 5 (7) 1
AST (U/L) 66.6 ± 47.9 48.1 ± 31.5 0.027 73.1 ± 49.3 51.3 ± 37.2 0.007
ALT (U/L) 62.4 ± 56.7 47.5 ± 52.4 0.164 61.0 ± 58.6 54.7 ± 53.6 0.547
Child-Pugh class A 60 (78) 27 (66) 0.189 20 (42) 67(96) <0.001
Albumin (g/dL) 3.6 ± 0.6 3.6 ± 0.6 0.862 3.0 ± 0.4 4.0 ± 0.4 <0.001
Total serum bilirubin(mg/dL) 1.2 ± 0.6 1.1 ± 0.5 0.456 1.4 ± 0.7 1.0 ± 0.4 <0.001
INR 1.1 ± 0.1 1.1 ± 0.1 0.906 1.2 ± 0.1 1.1 ± 0.1 <0.001
Ascites 9 (12) 12 (29) 0.023 16 (33) 5 (7) <0.001
WBC (×103/uL) 4.5 ± 1.7 5.3 ± 2.1 0.035 3.9 ± 1.7 5.4 ± 1.7 <0.001
Neutrophil count (%) 52.8 ± 7.9 69.6 ± 5.9 <0.001 58.6 ± 10.8 58.6 ± 11 0.996
Lymphocyte count (%) 34.8 ± 7.3 19.7 ± 4.5 <0.001 29.0 ± 9.8 29.9 ± 9.6 0.606
Platelet count (103/μL) 118.9 ± 58.2 130.5 ± 95.1 0.415 89.7 ± 45.4 145.7 ± 79.6 <0.001

NLR, neutrophil-to-lymphocyte ratio; PNI, prognostic nutritional index; HBsAg, hepatitis B surface antigen; HCV, hepatitis C virus; AFP, α-fetoprotein; AST, aspartate aminotransferase; ALT, alanine aminotransferase; INR, international normalized ratio of prothrombin time; WBC, white blood cell count.